immuno-oncology

Boehringer adds to cancer drug pipeline with deal for startup Nerio
BioPharma Dive
Mon, 07/29/24 - 11:01 am
Boehringer Ingelheim
M&A
Nerio Therapeutics
immuno-oncology
Bristol Myers Squibb closes immuno-oncology, cell therapy-focused Redwood City site
Fierce Biotech
Fri, 04/26/24 - 11:16 am
Bristol Myers Squibb
immuno-oncology
cell therapy
R&D
layoffs
Takeda inks sweet $1.2B+ deal with Kumquat for immuno-oncology program
Fierce Biotech
Tue, 04/16/24 - 10:10 pm
Takeda
Kumquat Biosciences
biobucks
immuno-oncology
BMS racks up phase III win in liver cancer targeted by AstraZeneca and Roche
BioSpace
Wed, 03/20/24 - 11:51 am
Bristol Myers Squibb
immuno-oncology
Opdivo
Yervoy
liver cancer
AstraZeneca
Roche
Asgard Gets $32M Series A Backing from J&J, Novo and Boehringer
BioSpace
Sun, 03/17/24 - 09:25 pm
Asgard Therapeutics
JNJ
Novo Nordisk
Boehringer Ingelheim
funding
immuno-oncology
Gilead invests $320M in Arcus to increase stake to 33%
Medical Marketing and Media
Wed, 01/31/24 - 10:32 pm
Gilead Sciences
Arcus Biosciences
immuno-oncology
Roche racks up phase 3 TIGIT win, but trial design leaves doubts
Fierce Biotech
Wed, 01/17/24 - 09:33 am
Roche
Tigit
immuno-oncology
tiragolumab
clinical trials
BioInvent Regains Rights to Immuno-Oncology Targets from Exelixis
BioSpace
Fri, 01/12/24 - 09:40 am
Bioinvent
Exelixis
immuno-oncology
How an AstraZeneca exec is leading the charge in the next immuno-oncology era
Pharma Voice
Fri, 08/18/23 - 10:15 am
AstraZeneca
immuno-oncology
Sutro strengthens its immuno-oncology pipeline with two new ADCs
Clinical Trials Arena
Fri, 08/11/23 - 10:03 am
Sutro BioPharma
immuno-oncology
antibody-drug conjugate
Takeda adds another F-Star collab to constellation, this time for $1B in biobucks
Fierce Biotech
Wed, 07/5/23 - 07:06 pm
Takeda
F-star Therapeutics
bispecific antibodies
immuno-oncology
2 small biotechs morph to work on oncology together
Fierce Biotech
Tue, 05/23/23 - 06:07 pm
CohBar
Morphogenesis
TuHURA Biosciences
immuno-oncology
Innovation in immuno-oncology: Leading companies in microbiota restoration therapy
Clinical Trials Arena
Mon, 05/8/23 - 10:37 am
immuno-oncology
microbiome
Agenus Receives Fast Track Designation for Botensilimab and Balstilimab in Colorectal Cancer
Yahoo/Businesswire
Tue, 04/18/23 - 10:10 am
Agenus
immuno-oncology
fast track
FDA
botensilimab
balstilimab
Zymeworks, Daiichi end $293M bispecific collab after 6 unfruitful years
Fierce Biotech
Mon, 03/20/23 - 09:56 am
Zymeworks
Daiichi Sankyo
immuno-oncology
biobucks
BeiGene pulls out of Leap of faith, letting option on immuno-oncology candidate lapse
Fierce Biotech
Fri, 03/17/23 - 09:55 am
BeiGene
immuno-oncology
Leap Therapeutics
DKN-01
Immuno-oncology goes subcutaneous
EP Vantage
Wed, 01/25/23 - 10:18 am
immuno-oncology
oncology
subcutaneous drug delivery
Keytruda
Merck
Tecentriq
Roche
10 months after first mega round, Glick's Odyssey raises $168M to gear up for entering clinic
Fierce Biotech
Thu, 10/13/22 - 09:18 am
Odyssey Therapeutics
venture capital
immunology
immuno-oncology
Moderna says yes to Autolus, licensing targeting technology for immuno-oncology project
Fierce Biotech
Wed, 10/12/22 - 10:53 am
Moderna Therapeutics
Autolus Therapeutics
MRNA
immuno-oncology
Personalized cancer therapy biotech PACT Pharma lets go of nearly 100 staffers
Fierce Biotech
Tue, 07/19/22 - 10:19 am
Pact Pharma
layoffs
immuno-oncology

Pages